.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Healthtrust
McKesson
Federal Trade Commission
Boehringer Ingelheim
Accenture
US Department of Justice
Citi
Mallinckrodt

Generated: November 20, 2017

DrugPatentWatch Database Preview

ZALEPLON Drug Profile

« Back to Dashboard

What is the patent landscape for Zaleplon, and what generic Zaleplon alternatives are available?

Zaleplon is a drug marketed by Cipla Ltd, Upsher-smith Labs, Aurobindo Pharma, West-ward Pharms Int, Mylan, Teva Pharms, Hikma Pharms, Orchid Hlthcare, and Unichem. and is included in ten NDAs.

The generic ingredient in ZALEPLON is zaleplon. There are twelve drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the zaleplon profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla Ltd
ZALEPLON
zaleplon
CAPSULE;ORAL077505-001Jun 20, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Unichem
ZALEPLON
zaleplon
CAPSULE;ORAL078989-002Jun 6, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
ZALEPLON
zaleplon
CAPSULE;ORAL077237-001Jun 6, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
ZALEPLON
zaleplon
CAPSULE;ORAL078706-002Jun 6, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
ZALEPLON
zaleplon
CAPSULE;ORAL077239-002Jun 6, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
ZALEPLON
zaleplon
CAPSULE;ORAL078095-002Jun 6, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
ZALEPLON
zaleplon
CAPSULE;ORAL077237-002Jun 6, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
ZALEPLON
zaleplon
CAPSULE;ORAL078095-001Jun 6, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Orchid Hlthcare
ZALEPLON
zaleplon
CAPSULE;ORAL090374-002Sep 17, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
ZALEPLON
zaleplon
CAPSULE;ORAL078147-002Nov 25, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Chubb
Fuji
Boehringer Ingelheim
McKesson
Merck
Federal Trade Commission
Harvard Business School
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot